BSD Medical has reported the positive study results of its BSD-2000 hyperthermia system, which is used to treat cancer.

The BSD-2000 hyperthermia system delivers localised therapeutic heating by applying radiofrequency energy to the tumour.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

The open-label comparative cohort study enrolled 60 patients with locally advanced and unresectable pancreatic cancer, and showed that patients treated using the hyperthermia system had an improved survival rate with no increase in toxicity.

The company is currently conducting a clinical study to evaluate the safety and efficacy of hyperthermia using the BSD-2000 combined with radiotherapy for the treatment of patients suffering from locally advanced, persistent or recurrent deep tumours of the pelvis.

BSD has also applied for a humanitarian device exemption approval for the device.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
SC MEDICA’s minimally invasive, radiation free spinal facet fixation system, FFX® is transforming spinal pain management and improving outcomes for surgeons and patients alike. Learn how SC MEDICA’s award-winning technology is redefining standards in facet joint pain treatment.

Discover the Impact